Your browser doesn't support javascript.
loading
Primary B cell engineering for therapeutic research.
Kleinboehl, Evan; Laoharawee, Kanut; Moriarity, Branden S.
Affiliation
  • Kleinboehl E; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.
  • Laoharawee K; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.
  • Moriarity BS; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA. Electronic address: mori0164@umn.edu.
Trends Mol Med ; 28(6): 528-529, 2022 06.
Article in En | MEDLINE | ID: mdl-35430120

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Therapeutic Human Experimentation / Gene Editing Limits: Humans Language: En Journal: Trends Mol Med Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Therapeutic Human Experimentation / Gene Editing Limits: Humans Language: En Journal: Trends Mol Med Year: 2022 Document type: Article